Patents by Inventor Jianyao Wang

Jianyao Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Metabolites of 5-fluoro-8- quinoline and methods of preparation and uses thereof
    Publication number: 20080262228
    Abstract: The present invention relates to novel metabolites of 5-Fluoro-8-{4-[4-(6-methoxyquinolin-8-yl)piperazin-1-yl]piperidin-1-yl}quinoline, which can be useful in treating CNS disorders. The present invention further relates to processes for their preparation, to pharmaceutical compositions comprising them, and to methods of using them.
    Type: Application
    Filed: November 27, 2007
    Publication date: October 23, 2008
    Applicant: Wyeth
    Inventors: Jianyao Wang, Alana Upthagrove, Lin Deng, Wayne Everett Childers, Zhongqi Shen, William Demaio, Robin D. Moore, Zeen Tong, Li Shen, Pixu Li, Michael K. May
  • Dihydrobenzofuran derivatives and uses thereof
    Patent number: 7402687
    Abstract: Compounds of formula I are described herein which are agonists or partial agonists of the 2C subtype of brain serotonin receptors. or pharmaceutically acceptable salts thereof, wherein each of R1, R2, R3, R4, Rx, Ry, and n are as defined herein. Such compounds, and compositions thereof, are useful for treating a variety of central nervous system disorders such as schizophrenia.
    Type: Grant
    Filed: April 21, 2006
    Date of Patent: July 22, 2008
    Assignee: Wyeth
    Inventors: Gary Paul Stack, Jianyao Wang, William Demaio, Ronald Jordan, John Chuck Lem Erve, Rasmy Elsayed Talaat, Matthew John Hoffmann
  • Dihydrobenzofuran derivatives and uses thereof
    Publication number: 20060241176
    Abstract: Compounds of formula I are described herein which are agonists or partial agonists of the 2C subtype of brain serotonin receptors. or pharmaceutically acceptable salts thereof, wherein each of R1, R2, R3, R4, Rx, Ry, and n are as defined herein. Such compounds, and compositions thereof, are useful for treating a variety of central nervous system disorders such as schizophrenia.
    Type: Application
    Filed: April 21, 2006
    Publication date: October 26, 2006
    Applicant: Wyeth
    Inventors: Gary Stack, Christine Huselton, Jianyao Wang, William Demaio, Ronald Jordan, John Erve, Rasmy Talaat, Matthew Hoffmann